Delta9‐tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|97|6|587-596

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.6, 2015-06, pp. : 587-596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabidiol does not reverse THC hypothermia

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 7, 2015-04 ,pp. : 1783-1791

John Wiley & Sons Inc

Access to resources Recommend Favorite

Respiratorische Insuffizienz durch Delta-9-Tetrahydrocannabinol bei tetraplegischem Patienten

By Neuburger M.   Schley M.   Schmelz M.   Schuepfer G.   Konrad C.  

Der Schmerz, Vol. 20, Iss. 6, 2006-11 ,pp. : 532-535

Springer Publishing Company

Access to resources Recommend Favorite

A metabolic interaction in vivo between cannabidiol and Δ1‐tetrahydrocannabinol

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 45, Iss. 2, 1972-06 ,pp. : 375-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urinary excretion of 11‐nor‐9‐carboxy‐ Δ 9 ‐ tetrahydrocannabinol: A case with an apparent long terminal half‐life

By Smith A.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 66, Iss. 2, 2006-04 ,pp. : 169-172

Informa Healthcare

Access to resources Recommend Favorite

Ovulation Inducing Agents and Cancer Risk: Review of Literature

By  

Current Drug Safety, Vol. 6, Iss. 4, 2011-09 ,pp. : 250-258

Bentham Science Publishers

Access to resources Recommend Favorite